Skip to content
Biodatica
Start free

Investigator

Elizabeth Marjorie Cespedes Feliciano

KAISER FOUNDATION RESEARCH INSTITUTE · funded by FDA, NCI

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$2.7M

Summed across those awards.

First award
Jul 1, 2020

Latest Sep 22, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. U01

    AI-Enabled Echocardiographic Biomarkers and Real-World Data for Predicting Cancer Therapy-Related Cardiac Dysfunction

    $1.5M

    Sep 22, 2025FDAKAISER FOUNDATION RESEARCH INSTITUTENIH RePORTER · 11390590 (opens the source filing in a new tab)

  2. R01

    Long-Term Trajectories of Accelerated Biological Aging and Functional Decline Associated with Breast Cancer and its Treatment

    $668k

    Sep 1, 2023NCIKAISER FOUNDATION RESEARCH INSTITUTENIH RePORTER · 11180970 (opens the source filing in a new tab)

  3. R01

    Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors

    $493k

    Jul 1, 2020NCIKAISER FOUNDATION RESEARCH INSTITUTENIH RePORTER · 11144496 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources